BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 28370561)

  • 1. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
    Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines.
    Lucero CM; Vega OA; Osorio MM; Tapia JC; Antonelli M; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Physiol; 2013 Apr; 228(4):714-23. PubMed ID: 22949168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
    Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
    J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
    Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of Runx2 by HSP90 controls osteosarcoma apoptosis via the AKT/GSK-3β/β-catenin signaling.
    Liang GH; Liu N; He MT; Yang J; Liang ZJ; Gao XJ; Rahhal AH; He QY; Zhang HT; Zha ZG
    J Cell Biochem; 2018 Jan; 119(1):948-959. PubMed ID: 28681940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility.
    van der Deen M; Akech J; Lapointe D; Gupta S; Young DW; Montecino MA; Galindo M; Lian JB; Stein JL; Stein GS; van Wijnen AJ
    J Biol Chem; 2012 Feb; 287(7):4503-17. PubMed ID: 22158627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
    Jiang Z; Jiang C; Fang J
    Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
    Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
    Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
    Zhu B; Cheng D; Li S; Zhou S; Yang Q
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
    Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
    Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of SOST Gene Silencing on Proliferation, Apoptosis, Invasion, and Migration of Human Osteosarcoma Cells Through the Wnt/β-Catenin Signaling Pathway.
    Zou J; Zhang W; Li XL
    Calcif Tissue Int; 2017 Jun; 100(6):551-564. PubMed ID: 28246931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental pathways hijacked by osteosarcoma.
    Mortus JR; Zhang Y; Hughes DP
    Adv Exp Med Biol; 2014; 804():93-118. PubMed ID: 24924170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of Sox2 Inhibits OS Cells Invasion and Migration via Modulating Wnt/β-Catenin Signaling Pathway.
    Tang L; Wang D; Gu D
    Pathol Oncol Res; 2018 Oct; 24(4):907-913. PubMed ID: 29619662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.
    Zhang C; Long F; Wan J; Hu Y; He H
    Oncol Rep; 2016 Jun; 35(6):3275-84. PubMed ID: 27035764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Methoxyestradiol-Mediated Induction of Frzb Contributes to Cell Death and Autophagy in MG63 Osteosarcoma Cells.
    Bravo D; Shogren KL; Zuo D; Wagner ER; Sarkar G; Yaszemski MJ; Maran A
    J Cell Biochem; 2017 Jun; 118(6):1497-1504. PubMed ID: 27883247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
    Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
    J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
    van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
    J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signaling in osteosarcoma.
    Lin CH; Ji T; Chen CF; Hoang BH
    Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway.
    Lv Z; Wang C; Yuan T; Liu Y; Song T; Liu Y; Chen C; Yang M; Tang Z; Shi Q; Weng Y
    Oncol Rep; 2014 Feb; 31(2):989-94. PubMed ID: 24337584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.